Long-term adverse effects of cyclophosphamide on follicular growth and angiogenesis in mouse ovaries

Reproductive Biology

Volumn 14, Issue 3, 2014, Pages 238-242

  Ezoe, Kenji ^a   Murata, Nana ^a   Yabuuchi, Akiko ^a   Okuno, Takashi ^a   Kobayashi, Tamotsu ^a   Kato, Osamu ^a   Kato, Keiichi ^a  

^a Kato Ladies Clinic   (Japan)

Author keywords

Angiogenesis; Corpus luteum; Cyclophosphamide; Follicular growth

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE;

ANGIOGENESIS; ANIMAL; APOPTOSIS; C57BL MOUSE; CORPUS LUTEUM; CYTOLOGY; DNA DAMAGE; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; MICROVASCULATURE; OOCYTE DEVELOPMENT; OVARY; OVARY FOLLICLE; RANDOMIZATION; TIME; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CORPUS LUTEUM; CYCLOPHOSPHAMIDE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MICE, INBRED C57BL; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; OOGENESIS; OVARIAN FOLLICLE; OVARY; RANDOM ALLOCATION; TIME FACTORS;

EID: 84906509605     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repbio.2014.04.007     Document Type: Article

References (15)

1. Chemaitilly W., Mertens A.C., Mitby P., Whitton J., Stovall M., Yasui Y., et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006, 91(5):1723-1728.
2. Brydøy M., Fosså S.D., Dahl O., Bjøro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol 2007, 46(4):480-489.
3. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000, 169(1/2):123-131.
4. Lobo R.A. Potential options for preservation of fertility in women. N Engl J Med 2005, 353(1):64-73.
5. Sonmezer M., Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004, 10(3):251-266.
6. Plowchalk D.R., Mattison D.R. Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and function. Reprod Toxicol 1992, 6(5):411-421.
7. Perez G.I., Knudson C.M., Leykin L., Korsmeyer S.J., Tilly J.L. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat Med 1997, 3(11):1228-1232.
8. Tsai-Turton M., Luong B.T., Tan Y., Luderer U. Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion. Toxicol Sci 2007, 98(1):216-230.
9. Oktem O., Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res 2007, 67(21):10159-10162.
10. Matsumoto H., Ezoe K., Mitsui A., Fukui E., Ochi M., Yoshizawa M. Vitrified-warmed ovarian tissue autotransplantation into ovariectomized mice restores sufficient ovarian function to support full-term pregnancy. Reprod Med Biol 2011, 10(3):185-191.
11. Takehara Y., Yabuuchi A., Ezoe K., Kuroda T., Yamadera R., Sano C., et al. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest 2013, 93(2):181-193.
12. Charnock-Jones D.S., Sharkey A.M., Rajput-Williams J., Burch D., Schofield J.P., Fountain S.A., et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993, 48(5):1120-1128.
13. Yan Z., Weich H.A., Bernart W., Breckwoldt M., Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab 1993, 77(6):1723-1725.
14. Kamat B.R., Brown L.F., Manseau E.J., Senger D.R., Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 1995, 146(1):157-165.
15. Zimmermann R.C., Hartman T., Kavic S., Pauli S.A., Bohlen P., Sauer M.V., et al. Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 2003, 112(5):659-669.